Metrion Biosciences Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 47

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.06M

  • Investors
  • 7

Metrion Biosciences General Information

Description

Operator of a contract research organization intended to focus on delivering a range of preclinical drug discovery screening services. The company's platform provides highly skilled electrophysiology screening services in multiple formats for medicinal chemistry support, and also offers flexible business models according to the scope of each program, with both fee-for-service and collaborative options and options to access integrated drug discovery services, enabling clients with the support of medicinal chemistry optimization programs, compliant cardiac safety profiling assays, neuroscience assays, and translational assays.

Contact Information

Website
www.metrionbiosciences.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 2, Granta Centre, Great Abington
  • First Floor
  • Cambridge CB21 6AL
  • England, United Kingdom
+44 01223
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Industrials, Life Sciences
Corporate Office
  • Building 2, Granta Centre, Great Abington
  • First Floor
  • Cambridge CB21 6AL
  • England, United Kingdom
+44 01223

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Metrion Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 20-Dec-2023 $4.06M Completed Generating Revenue
12. Later Stage VC (Series AAA) 06-Apr-2021 Completed Generating Revenue
11. Grant 01-Oct-2020 Completed Generating Revenue
10. Grant 01-Jun-2020 Completed Generating Revenue
9. Grant 01-Jul-2019 Completed Generating Revenue
8. Early Stage VC 01-Apr-2019 Completed Generating Revenue
7. Grant 01-Sep-2018 Completed Generating Revenue
6. Grant 28-Aug-2018 Completed Generating Revenue
5. Early Stage VC 30-Apr-2018 $1.34M $1.34M Completed Generating Revenue
4. Grant 01-Feb-2018 $194K Completed Startup
To view Metrion Biosciences’s complete valuation and funding history, request access »

Metrion Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
B PREFERENCE
B ORDINARY
2023 A PREFERENCE
Ordinary
Ordinary
A Preference
Ordinary 106,663 $0.010884 $4.08 $4.08 1x $4.08 7.19%
Ordinary 191,125 $0.010884 $5.44 $5.44 1x $5.44 12.89%
To view Metrion Biosciences’s complete cap table history, request access »

Metrion Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a contract research organization intended to focus on delivering a range of preclinical drug discovery scree
Drug Discovery
Cambridge, United Kingdom
47 As of 2024

Nottingham, United Kingdom
 

Shanghai, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Metrion Biosciences Competitors (31)

One of Metrion Biosciences’s 31 competitors is Sygnature Discovery, a Private Equity-Backed company based in Nottingham, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom
Shanghai Medicilon Formerly VC-backed Shanghai, China
Thousand Oaks Biopharmaceuticals Venture Capital-Backed Nantong, China
Sphere Fluidics Venture Capital-Backed Cambridge, United Kingdom
Gyre Therapeutics Formerly VC-backed San Diego, CA
You’re viewing 5 of 31 competitors. Get the full list »

Metrion Biosciences Patents

  • 19

    Total Documents Applications and Grants

  • Total Patents Families

  • 16

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Metrion Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201811165-D0 Novel compounds Inactive 06-Jul-2018
US-20210275499-A1 Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof Active 06-Jul-2018
CA-3105757-A1 Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof Pending 06-Jul-2018
US-12128028-B2 Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof Active 06-Jul-2018
US-20250082609-A1 Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof Pending 06-Jul-2018 A61K31/4164
To view Metrion Biosciences’s complete patent history, request access »

Metrion Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Metrion Biosciences Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Maven Capital Partners (Glasgow) PE/Buyout Minority
Gresham House Asset Manager Minority
O2h Ventures Venture Capital Minority
Biomedical Catalyst Government
SyndicateRoom Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Metrion Biosciences FAQs

  • When was Metrion Biosciences founded?

    Metrion Biosciences was founded in 2015.

  • Where is Metrion Biosciences headquartered?

    Metrion Biosciences is headquartered in Cambridge, United Kingdom.

  • What is the size of Metrion Biosciences?

    Metrion Biosciences has 47 total employees.

  • What industry is Metrion Biosciences in?

    Metrion Biosciences’s primary industry is Drug Discovery.

  • Is Metrion Biosciences a private or public company?

    Metrion Biosciences is a Private company.

  • What is the current valuation of Metrion Biosciences?

    The current valuation of Metrion Biosciences is .

  • What is Metrion Biosciences’s current revenue?

    The current revenue for Metrion Biosciences is .

  • How much funding has Metrion Biosciences raised over time?

    Metrion Biosciences has raised $9.7M.

  • Who are Metrion Biosciences’s investors?

    Maven Capital Partners (Glasgow), Gresham House, O2h Ventures, Biomedical Catalyst, and SyndicateRoom are 5 of 7 investors who have invested in Metrion Biosciences.

  • Who are Metrion Biosciences’s competitors?

    Sygnature Discovery, Shanghai Medicilon, Thousand Oaks Biopharmaceuticals, Sphere Fluidics, and Gyre Therapeutics are some of the 31 competitors of Metrion Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »